RADx-UP SAY YES COVID Test Study (S4)
$5,500,000U24FY2021MDNIH
Duke University, Durham NC
Investigators
Linked publications, trials & patents
Paper 39658289Paper 39228276Paper 38863862Paper 38776503Paper 38661832Paper 38547469Paper 38547468Paper 38547467Paper 38547462Paper 38315120Paper 38243779Paper 37971996Paper 37841714Paper 37395655Paper 37394512Paper 37394510Paper 37394506Paper 37394505Paper 37394504Paper 37394503Paper 37394502Paper 37394501Paper 37394499Paper 37250998Paper 36704996Paper 36633812Paper 36404728Paper 36328395Paper 36194852Paper 36061814Paper 35820879Paper 35678579Paper 35437593Paper 35260896Paper 35184256Paper 34863144Paper 34737181Paper 34737180Paper 34737179Paper 34737178Paper 34737177Paper 34737176Paper 34737175Paper 34737173Paper 34737172Paper 34737171Paper 34737170Paper 34155614Paper 33963084Trial NCT05884515Trial NCT05435482Trial NCT05212883
Abstract
This supplement will follow the approved Abstract under RADx-UP 3U24-MD016258-01S1. As requested by the NIH, we will deploy the SAY YES! COVID Test pilot in two additional communities likely to experience surges in SARS-CoV-2 infections. These additional communities will not be subject to the sub-study.
View original record on NIH RePORTER →